MedTrace Logo

Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant Therapy

NCT01645059 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2014-01-08

Study results available
· View outcomes & findings →

Summary

This is an observational, cross-sectional study that the main objective is to describe the patient clinical profile that begins with disseminated Her 2+ Breast Cancer or develops a metastasis after or during the adjuvant treatment.

Conditions

  • Disseminated HER2+ Breast Cancer

Sponsors & Collaborators

  • Asociación Cacereña para la Investigación y el Desarrollo en Oncología Médica

    lead NETWORK

Principal Investigators

  • Mª Helena López Ceballos, MD · Hospital San Pedro Alcántara

  • Santiago González Santiago, MD · Hospital San Pedro Alcántara

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01645059 on ClinicalTrials.gov